Correction

Oct 4, 2004
In our last Letter from the Editor, we incorrectly reported the name of Schering's Primovist MRI contrast agent in our story about European Union approval of the product.
Latest in Clinical News
Canada Flag 400
Report urges reform of Canadian preventive care guideline development
June 13, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
Ratio Therapeutics partners with Macrocyclics
June 13, 2025
Register today for our June 17 webinar
Sponsored
Register today for our June 17 webinar
June 3, 2025
Viz Ai Image Thumbnail
Viz.ai gets FDA nod for Viz Subdural Plus
June 12, 2025
Related Stories
2002 09 30 15 13 07 706
Breast
When push comes to shove: Addressing compression in mammography
2002 09 30 15 13 07 706
Breast
Preparation key to surviving MQSA inspections
2004 10 01 16 15 54 706
Clinical News
Biochem enters ultrasound domain in fetal screening
Join Us June 26 at 12 Noon ET for a FREE webinar!
Sponsor Content
Join Us June 26 at 12 Noon ET for a FREE webinar!
More in Clinical News
Report urges reform of Canadian preventive care guideline development
By Amerigo Allegretto
The Public Health Agency of Canada has released a new report recommending reforms to how preventive health guidelines are developed.
June 13, 2025
Canada Flag 400
Ratio Therapeutics partners with Macrocyclics
By AuntMinnie.com staff writers
The agreement will enable access to Macropa in Japan, Canada, Australia, and a majority of Europe, according to Ratio.
June 13, 2025
Ame 2018 12 11 00 02 7009 Atom Nuclear Lab 400
PSMA-PET/CT improves survival in men with prostate cancer
By Will Morton
Researchers report that PSMA-PET/CT improves survival in men with recurrent prostate cancer treated with salvage radiotherapy.
June 12, 2025
2025 06 12 Visual Abstract Thumbnail
Viz.ai gets FDA nod for Viz Subdural Plus
By AuntMinnie.com staff writers
Viz.ai's Viz Subdural Plus software has received U.S. Food and Drug Administration (FDA) 510(k) clearance.
June 12, 2025
Viz Ai Image Thumbnail
GE HealthCare highlights combined software with MIM Encore
By AuntMinnie.com staff writers
GE HealthCare has combined its software features and algorithms with the MIM Encore platform.
June 12, 2025
Ge Health Care Logo
MolecuLight touts published research on i:X device
By AuntMinnie.com staff writers
MolecuLight is highlighting research showing the efficacy of MolecuLight's i:X device on managing deep sternal wound infections.
June 12, 2025
Molecu Light Logo
Patient navigation lifts breast, cervical cancer screening rates
By Amerigo Allegretto
Breast and cervical cancer screening increased by about 14% and 15%, respectively, when patient navigation services were provided in the study.
June 11, 2025
Mammogram Calendar 400
Radiopharm secures fast-track designation for brain PET tracer
By AuntMinnie.com staff writers
Radiopharm has received fast-track designation from the U.S. Food and Drug Administration for its F-18 RAD101 PET radiotracer.
June 11, 2025
Brain Theranostics2
Positrigo closes $8.5M funding round
By AuntMinnie.com staff writers
Firm also notes board changes.
June 10, 2025
Money Pile 400
Applying ADC cutoff value finds more breast lesions on MRI
By Amerigo Allegretto
Applying an apparent diffusion coefficient (ADC) cutoff based on MRI with diffusion-weighted imaging may improve breast lesion detection.
June 10, 2025
2025 06 10 Radiology Dwi Mri Breast Thumbnail
Study explores PPVs of LI-RADS major feature combinations
By Will Morton
Most major feature combinations in the same CT/MRI LI-RADS categories have similar positive predictive values (PPV) for liver cancer in high-risk patients.
June 10, 2025
Liver Cancer
CT colonography more cost-effective than DNA stool testing
By Amerigo Allegretto
CT colonography for cancer screening is more effective, both clinically and cost-wise, than multitarget stool DNA testing.
June 10, 2025
2025 06 10 Radiology Ct Colonography Thumbnail
Page 1 of 3655
Next Page